The news is by your side.


AstraZeneca rebuilds cancer drug hopes with new lung data

MADRID: Two AstraZeneca drugs tackling lung cancer in different ways delivered impressive clinical results on Saturday, helping the British group offset July’s big clinical trial setback in the disease. Particularly notable was the success of the infused immunotherapy medicine Imfinzi in helping non-small cell lung cancer patients with inoperable mid-stage disease that has not spread widely around the body. Chief Executive Pascal Soriot said it gave AstraZeneca a chance to intervene earlier in lung cancer,…

High-fat diet linked to lung cancer risk: study

NASHVILLE, US: People who eat a lot of saturated fat - the “bad” kind of fat that’s abundant in foods like butter and beef - are more likely to develop lung cancer than individuals on low-fat diets, a recent study suggests. Compared to adults who didn’t get a lot of fat in their diets, people who ate the most total fat and saturated fat were 14 percent more likely to get lung malignancies, the study found. For current and former smokers, the added risk of a high fat diet was 15 percent. While the best way to lower the…

Czech scientists develop human lung model to aid treatments

PRAGUE: Czech scientists have developed a model of a functioning human lung that can be used to simulate problems like asthma or other chronic diseases and their treatments. The research group from the Brno University of Technology says its mechanical- and computer-based model of the lung can help devise treatment methods with more precision than past testing and tailor it to individual patients. It can also be used as a reference model for developing inhaled drugs. "This model will show whether an inhaled drug will…